Know Cancer

forgot password

Attitudes About Childbearing And Fertility In Women Seeking Genetic Testing For Inherited Breast And Ovarian Cancer Syndromes (HBOC)

18 Years
Open (Enrolling)
Breast Cancer, Ovarian Cancer

Thank you

Trial Information

Attitudes About Childbearing And Fertility In Women Seeking Genetic Testing For Inherited Breast And Ovarian Cancer Syndromes (HBOC)

This questionnaire is part of a study at The University of Texas M.D. Anderson Cancer
Center. The purpose is to ask women who are seeking genetic testing for HBOC their
viewpoints surrounding fertility, childbearing and parenting, both at the time of testing
and at the time of results disclosure. The aim is to evaluate if the genetics results
disclosure may influence women's views regarding these topics. Researchers hope to use this
information to provide more information to the patient and the caregiver to help both
parties with this very important cancer survivorship issue.

Inclusion Criteria:

1. Women who have been referred to the Clinical Cancer Genetics Program for discussion
of Hereditary Breast And Ovarian Syndrome (HBOC).

2. Participants must be seen by clinical cancer geneticist and undergo genetic
counseling here at M.D. Anderson Cancer Center for HBOC.

3. Participants may or may not have a personal diagnosis of cancer.

4. Participants may have already seen or undergone reproductive endocrine evaluation and
had any reproductive treatment.

5. The participant must be a woman and have reproductive potential which would include
either active menstruation, blood tests with premenopausal ranges of Luteinizing
Hormone (LH), Follicle Stimulating Hormone (FSH) and estradiol, or was premenopausal
prior to starting chemotherapy for a diagnosed breast cancer.

6. Age >/= 18 years old

7. The patient must be able to speak and read fluently in either English or in Spanish
in order to complete the questionnaire.

Exclusion Criteria:

1) None

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Women Endorsing Prenatal Diagnostic Testing (Questionnaire response)

Outcome Time Frame:

Baseline and post genetic testing (results disclosure) at 3-4 weeks

Safety Issue:


Principal Investigator

Jennifer Litton, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

UT MD Anderson Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

February 2009

Completion Date:

Related Keywords:

  • Breast Cancer
  • Ovarian Cancer
  • Ovary, Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Hereditary Breast and Ovarian Cancer Syndrome
  • HBOC
  • Genetic testing
  • Pregnancy
  • Fertility
  • Prenatal diagnostic testing
  • Breast Neoplasms
  • Ovarian Neoplasms



UT MD Anderson Cancer CenterHouston, Texas  77030